JP2023542640A5 - - Google Patents
Info
- Publication number
- JP2023542640A5 JP2023542640A5 JP2023515691A JP2023515691A JP2023542640A5 JP 2023542640 A5 JP2023542640 A5 JP 2023542640A5 JP 2023515691 A JP2023515691 A JP 2023515691A JP 2023515691 A JP2023515691 A JP 2023515691A JP 2023542640 A5 JP2023542640 A5 JP 2023542640A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- vitamin
- cells
- nad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20198622 | 2020-09-28 | ||
| EP20198622.1 | 2020-09-28 | ||
| PCT/EP2021/076659 WO2022064063A1 (en) | 2020-09-28 | 2021-09-28 | Compositions and methods for increasing stem cell function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542640A JP2023542640A (ja) | 2023-10-11 |
| JP2023542640A5 true JP2023542640A5 (enExample) | 2024-06-07 |
Family
ID=72665075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515691A Pending JP2023542640A (ja) | 2020-09-28 | 2021-09-28 | 幹細胞機能を向上させるための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230365933A1 (enExample) |
| EP (1) | EP4217470A1 (enExample) |
| JP (1) | JP2023542640A (enExample) |
| CN (1) | CN116391031A (enExample) |
| AU (1) | AU2021350472A1 (enExample) |
| BR (1) | BR112023005375A2 (enExample) |
| CA (1) | CA3188667A1 (enExample) |
| WO (1) | WO2022064063A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202319994D0 (en) * | 2023-12-22 | 2024-02-07 | Amazentis Sa | Compositions for use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5723315A (en) | 1996-08-23 | 1998-03-03 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| PT968182E (pt) | 1996-08-07 | 2004-08-31 | Darwin Discovery Ltd | Derivados de acidos hidroxamicos e carboxilicos com actividade inibidora da mpm e do fnt |
| US6126939A (en) | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
| EP2995948A1 (en) * | 2014-09-09 | 2016-03-16 | Ecole Polytechnique Federale de Lausanne (EPFL) | Methods and compounds useful in hematopoietic stem cell medicine |
| CN104830772A (zh) * | 2015-05-28 | 2015-08-12 | 深圳富利鑫健康产业发展有限公司 | 一种造血干细胞培养基及其应用和干细胞培养方法 |
| ES2832506T3 (es) * | 2015-12-24 | 2021-06-10 | Amazentis Sa | Composiciones que comprenden ribósido de nicotinamida y una urolitina |
| CA3126190A1 (en) * | 2019-01-18 | 2020-07-23 | Societe Des Produits Nestle S.A. | Agents and methods for increasing stem cell function |
| US20220168271A1 (en) * | 2019-03-29 | 2022-06-02 | Societe Des Produits Nestle S.A. | Compositions and methods for increasing t cell function |
-
2021
- 2021-09-28 CN CN202180063423.6A patent/CN116391031A/zh active Pending
- 2021-09-28 WO PCT/EP2021/076659 patent/WO2022064063A1/en not_active Ceased
- 2021-09-28 BR BR112023005375A patent/BR112023005375A2/pt unknown
- 2021-09-28 US US18/246,710 patent/US20230365933A1/en active Pending
- 2021-09-28 EP EP21783279.9A patent/EP4217470A1/en active Pending
- 2021-09-28 CA CA3188667A patent/CA3188667A1/en active Pending
- 2021-09-28 JP JP2023515691A patent/JP2023542640A/ja active Pending
- 2021-09-28 AU AU2021350472A patent/AU2021350472A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Macmillan et al. | Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial | |
| US20250235488A1 (en) | Compositions and methods for providing hematopoietic function | |
| US20190298778A1 (en) | Compositions and methods for providing hematopoietic function without hla matching | |
| US20080057042A1 (en) | Method of providing readily available cellular material derived from cord blood, and a composition thereof | |
| JP2023543149A5 (enExample) | ||
| US20080075704A1 (en) | Method of providing readily available cellular material derived from peripheral blood, and a composition thereof | |
| US12551523B2 (en) | HIF-1 activator | |
| KR20130015481A (ko) | 적혈구의 인 비트로 대량 생산방법 및 이의 저장 방법 | |
| JP2023543149A (ja) | 幹細胞機能を向上させるための組成物及び方法 | |
| JP2023542640A (ja) | 幹細胞機能を向上させるための組成物及び方法 | |
| JP2024516187A5 (enExample) | ||
| Cancelas | On how Rac controls hematopoietic stem cell activity | |
| JP7497094B1 (ja) | 腸内細菌叢改善のための組成物及びその応用 | |
| Bhattacharya et al. | Frontiers of cord blood science | |
| JP2018050551A (ja) | 造血幹細胞の分化促進剤 | |
| Soboleva | Blood in a Lab: Using Immortalized Erythroid Cell Lines as a Source for Blood Transfusion | |
| CN121015664A (zh) | 一种牛磺脱氧胆酸在制备恢复受损造血干细胞的药物中的应用 | |
| HK40095240A (zh) | 用於增加干细胞功能的组合物和方法 | |
| HK40096626A (zh) | 用於增加干细胞功能的组合物和方法 | |
| CA2597963A1 (en) | Method of providing readily available cellular material derived from peripheral blood and a composition thereof | |
| Chao et al. | Effects of paeoniflorin on the proliferation of bone marrow mesenchymal stem cells | |
| Kunisawa | Vitamin B9 and ATP in the control and development of intestinal inflammation | |
| HK1231737A1 (en) | Compositions and methods for providing hematopoietic function without hla matching | |
| HK1231737B (en) | Compositions and methods for providing hematopoietic function without hla matching | |
| HK1231736A1 (en) | Compositions and methods for providing hematopoietic function |